User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
This presentation on Dietary Factors & Polycystic Kidney Disease (PKD): Dietary Interventions, reviews human composite dietary intervention trials conducted in patients with autosomal dominant polycystic kidney disease (ADPKD). These dietary interventions include reductions in dietary sodium and protein to reduce solute load, increasing fluid intake to control vasopressin, and increasing fruit and vegetable intake to […]
This presentation on Dietary Factors & Polycystic Kidney Disease (PKD): Dietary Interventions, reviews human composite dietary intervention trials conducted in patients with autosomal dominant polycystic kidney disease (ADPKD). These dietary interventions include reductions in dietary sodium and protein to reduce solute load, increasing fluid intake to control vasopressin, and increasing fruit and vegetable intake to […]
Did you know that COVID-19 is affecting Black, Indigenous, Latinx and other people of color more than Caucasians? Did you know that in the United States, Black people are dying at 2.5 times the rate of White people?1 Please join us for a virtual panel discussion, led by nephrology and mental health experts from across […]
With the advancement of technology throughout the 21st century, we have seen a growing role for the utilization of information technology applied to health and healthcare. Health information technology (HIT), including HIT used by patients, can play an important role in patient empowerment by creating new opportunities for patients and families to participate actively in […]
A regional Virtual Live Event for PsychU members in KS and OK, and NephU members in NM, OK, TX, and AR.There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the […]
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology. This is a Regional Virtual Live Event for the Garden State Chapter of […]
Join us as we discuss the challenges patients with end-stage kidney disease face and explore the barriers and benefits of living kidney donation. Our speaker, Glenna Frey, APRN-CNS, is an advanced practice provider with over 35 years of nephrology nursing and oncology experience. Apart from being a healthcare provider, Glenna Frey is the co-founder and […]
Join us as we discuss the challenges patients with end-stage kidney disease face and explore the barriers and benefits of living kidney donation. Our speaker, Glenna Frey, APRN-CNS, is an advanced practice provider with over 35 years of nephrology nursing and oncology experience. Apart from being a healthcare provider, Glenna Frey is the co-founder and […]
As part of our Patient Empowerment series, this presentation brings you concepts and resources to help improve health literacy among your patients, especially those with chronic kidney disease, as they manage the complexities of their care regimen. Health literacy is crucial for dialysis and transplant patients so they can be empowered to participate in shared […]
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology. This is a Regional Virtual Live Event for the Garden State Chapter of […]
Join PKD experts from across the country, where you can hear the most current information on PKD pathophysiology, disease progression, and the physical and emotional burden of PKD. Objectives Review of the recent advancements made in the PKD fieldAddress key factors that play into PKDHighlight and evaluate prognostic indicators of advanced PKD outcomes *Speakers are […]
Did you know that Black patients with autosomal dominant polycystic kidney disease (ADPKD) progress to end-stage kidney disease (ESKD) earlier than White patients?1,2 Please join us for a virtual panel discussion, led by nephrology experts, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease (ADPKD), underrepresentation of Black […]
